These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27107739)

  • 1. Mononuclear phagocytes contribute to intestinal invasion and dissemination of Yersinia enterocolitica.
    Drechsler-Hake D; Alamir H; Hahn J; Günter M; Wagner S; Schütz M; Bohn E; Schenke-Layland K; Pisano F; Dersch P; Autenrieth IB; Autenrieth SE
    Int J Med Microbiol; 2016 Sep; 306(6):357-66. PubMed ID: 27107739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yersinia enterocolitica invasin-dependent and invasin-independent mechanisms of systemic dissemination.
    Handley SA; Newberry RD; Miller VL
    Infect Immun; 2005 Dec; 73(12):8453-5. PubMed ID: 16299350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peyer's patches play a protective role in nonsteroidal anti-inflammatory drug-induced enteropathy in mice.
    Hiyama S; Iijima H; Shinzaki S; Inoue T; Shiraishi E; Kawai S; Araki M; Kato M; Hayashi Y; Nishida T; Fujii H; Mukai A; Shibata N; Sato S; Kiyono H; Gotoh K; Motooka D; Nakamura S; Iida T; Tsujii M; Takehara T
    Inflamm Bowel Dis; 2014 May; 20(5):790-9. PubMed ID: 24651581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of M cells and destruction of Peyer's patches by Yersinia enterocolitica: an ultrastructural and histological study.
    Autenrieth IB; Firsching R
    J Med Microbiol; 1996 Apr; 44(4):285-94. PubMed ID: 8606357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yersinia enterocolitica infection of mice reveals clonal invasion and abscess formation.
    Oellerich MF; Jacobi CA; Freund S; Niedung K; Bach A; Heesemann J; Trülzsch K
    Infect Immun; 2007 Aug; 75(8):3802-11. PubMed ID: 17562774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasion and dissemination of Yersinia enterocolitica in the mouse infection model.
    Trülzsch K; Oellerich MF; Heesemann J
    Adv Exp Med Biol; 2007; 603():279-85. PubMed ID: 17966424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-1-Driven Tolerogenic Programs Aggravate
    Davicino RC; Méndez-Huergo SP; Eliçabe RJ; Stupirski JC; Autenrieth I; Di Genaro MS; Rabinovich GA
    J Immunol; 2017 Aug; 199(4):1382-1392. PubMed ID: 28716827
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo analysis of Yersinia enterocolitica infection using luxCDABE.
    Trcek J; Berschl K; Trülzsch K
    FEMS Microbiol Lett; 2010 Jun; 307(2):201-6. PubMed ID: 20636977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA response by oral infection with an attenuated Yersinia enterocolitica mutant: implications for its use as oral carrier vaccine.
    Blanco HM; Lacoste MG; Eliçabe RJ; Di Genaro MS
    Vaccine; 2008 Dec; 26(51):6497-502. PubMed ID: 18835575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased susceptibility to Yersinia enterocolitica Infection of Tff2 deficient mice.
    Shah AA; Mihalj M; Ratkay I; Lubka-Pathak M; Balogh P; Klingel K; Bohn E; Blin N; Baus-Loncar M
    Cell Physiol Biochem; 2012; 30(4):853-62. PubMed ID: 22907484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defense mechanisms in Peyer's patches and mesenteric lymph nodes against Yersinia enterocolitica involve integrins and cytokines.
    Autenrieth IB; Kempf V; Sprinz T; Preger S; Schnell A
    Infect Immun; 1996 Apr; 64(4):1357-68. PubMed ID: 8606101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune evasion by Yersinia enterocolitica: differential targeting of dendritic cell subpopulations in vivo.
    Autenrieth SE; Linzer TR; Hiller C; Keller B; Warnke P; Köberle M; Bohn E; Biedermann T; Bühring HJ; Hämmerling GJ; Rammensee HG; Autenrieth IB
    PLoS Pathog; 2010 Nov; 6(11):e1001212. PubMed ID: 21124820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of CCR7 on T-Cell Response and Susceptibility to Yersinia pseudotuberculosis Infection.
    Pezoldt J; Pisano F; Heine W; Pasztoi M; Rosenheinrich M; Nuss AM; Pils MC; Prinz I; Förster R; Huehn J; Dersch P
    J Infect Dis; 2017 Sep; 216(6):752-760. PubMed ID: 28329174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphology of intestinal colonization of Yersinia enterocolitica serovar O3 in mice.
    Kaneko K; Uehara K; Hayashidani H; Ogawa M
    J Vet Med Sci; 1999 Oct; 61(10):1171-3. PubMed ID: 10563299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta and CD25 are important for controlling systemic dissemination following Yersinia enterocolitica infection of the gut.
    Zhong Y; Cantwell A; Dube PH
    Infect Immun; 2010 Sep; 78(9):3716-25. PubMed ID: 20584975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of professional phagocytes dictates the number of host cells targeted for Yop translocation during infection.
    Durand EA; Maldonado-Arocho FJ; Castillo C; Walsh RL; Mecsas J
    Cell Microbiol; 2010 Aug; 12(8):1064-82. PubMed ID: 20148898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide O antigen status of Yersinia enterocolitica O:8 is essential for virulence and absence of O antigen affects the expression of other Yersinia virulence factors.
    Bengoechea JA; Najdenski H; Skurnik M
    Mol Microbiol; 2004 Apr; 52(2):451-69. PubMed ID: 15066033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of oral Yersinia enterocolitica infection in three different strains of inbred mice.
    Handley SA; Dube PH; Revell PA; Miller VL
    Infect Immun; 2004 Mar; 72(3):1645-56. PubMed ID: 14977972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on pathogenicity of Yersinia enterocolitica in mice with diabetes mellitus.
    Dima VF; Ionescu MD; Popa C; Balotescu C; Laky D; Dima SV
    Roum Arch Microbiol Immunol; 1999; 58(2):157-76. PubMed ID: 11845454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yersinia enterocolitica YopH-Deficient Strain Activates Neutrophil Recruitment to Peyer's Patches and Promotes Clearance of the Virulent Strain.
    Dave MN; Silva JE; Eliçabe RJ; Jeréz MB; Filippa VP; Gorlino CV; Autenrieth S; Autenrieth IB; Di Genaro MS
    Infect Immun; 2016 Nov; 84(11):3172-3181. PubMed ID: 27550935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.